CANNAPHARMARX, INC. Quarterly Debt-to-equity in % from Q3 2015 to Q1 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Cannapharmarx, Inc. quarterly Debt-to-equity history and growth rate from Q3 2015 to Q1 2024.
  • Cannapharmarx, Inc. Debt-to-equity for the quarter ending March 31, 2024 was -144 %, a 7.8% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 -144 -10.4 -7.8% Mar 31, 2024
Q4 2023 -139 -1.94 -1.42% Dec 31, 2023
Q3 2023 -128 +2.52 +1.94% Sep 30, 2023
Q2 2023 -130 +8.75 +6.29% Jun 30, 2023
Q1 2023 -134 +21.4 +13.8% Mar 31, 2023
Q4 2022 -137 +39.7 +22.5% Dec 31, 2022
Q3 2022 -130 +87.7 +40.2% Sep 30, 2022
Q2 2022 -139 +169 +54.9% Jun 30, 2022
Q1 2022 -155 +381 +71.1% Mar 31, 2022
Q4 2021 -176 +1.6K +90.1% Dec 31, 2021
Q3 2021 -218 -714 -144% Sep 30, 2021
Q2 2021 -308 -523 -243% Jun 30, 2021
Q1 2021 -536 -675 -487% Mar 31, 2021
Q4 2020 -1.77K -1.87K -1982% Dec 31, 2020
Q3 2020 496 +390 +371% Sep 30, 2020
Q2 2020 215 +80.8 +60% Jun 30, 2020
Q1 2020 139 -85.4 -38.1% Mar 31, 2020
Q4 2019 94.2 +515 Dec 31, 2019
Q3 2019 105 +225 Sep 30, 2019
Q2 2019 135 +235 Jun 30, 2019
Q1 2019 224 +324 Mar 31, 2019
Q4 2018 -421 -321 -321% Dec 31, 2018
Q3 2018 -119 -19.2 -19.1% Sep 30, 2018
Q2 2018 -101 -0.42 -0.42% Jun 30, 2018
Q1 2018 -100 +0.36 +0.36% Mar 31, 2018
Q4 2017 -100 +0.94 +0.93% Dec 31, 2017
Q3 2017 -100 +1.29 +1.27% Sep 30, 2017
Q2 2017 -100 +13.8 +12.1% Jun 30, 2017
Q1 2017 -100 +110 +52.3% Mar 31, 2017
Q4 2016 -101 +291 +74.3% Dec 31, 2016
Q3 2016 -101 +752 +88.1% Sep 30, 2016
Q2 2016 -114 Jun 30, 2016
Q1 2016 -210 Mar 31, 2016
Q4 2015 -392 Dec 31, 2015
Q3 2015 -853 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.